Neurotoxicity of vincristine on the medial olivocochlear bundle

International Journal of Pediatric Otorhinolaryngology

Volumn 71, Issue 1, 2007, Pages 63-69

  Riga, M ^a   Psarommatis, I ^a   Korres, S ^b   Varvutsi, M ^a   Giotakis, I ^a   Apostolopoulos, N ^a   Ferekidis, E ^a  

^a P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Neurotoxicity; Otoacoustic emissions; Suppression; Vincristine

Indexed keywords

VINCRISTINE;

ACOUSTIC REFLEX; AMPLITUDE MODULATION; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; DOSE RESPONSE; EVOKED OTOACOUSTIC EMISSION; FEMALE; FREQUENCY MODULATION; FUNCTIONAL ANATOMY; HEARING; HUMAN; LEUKEMIA; MALE; MDIAL OLIVOCOCHLEAR BUNDLE; NERVE FIBER; NEUROTOXICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PURE TONE AUDIOMETRY; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TYMPANOMETRY; WHITE NOISE;

ACOUSTIC STIMULATION; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AUDIOMETRY, PURE-TONE; CHILD; COCHLEA; HAIR CELLS, OUTER; HUMANS; LEUKEMIA; OLIVARY NUCLEUS; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PROSPECTIVE STUDIES; VINCRISTINE;

EID: 33845681602     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2006.09.001     Document Type: Article

References (47)

1. Kaplan R.S., and Wiernik P.H. Neurotoxicity of antineoplastic drugs. Semin. Oncol. 9 (1982) 103-130
2. McCarthy G.M., and Skillings J.R. Jaw and other orofacial pain in patients receiving vincristine for the treatment of cancer. Oral. Surg. Oral. Med. Pathol. 74 (1992) 299-304
3. Legha S.S. Vincristine neurotoxicity. Pathophysiology and management. Med. Toxicol. 1 6 (1986) 421-427
4. Ogawa T., Mimura Y., Kato H., Ootsubo S., and Murakoshi M. The usefulness of rabbits as an animal model for the neuropathological assessment of neurotoxicity following administration of vincristine. Neurotoxicology 21 (2000) 501-512
5. Lugassy G., and Shapira A. A prospective cohort study of the effect of vincristine on audition. Anticancer Drugs 7 5 (1996) 525-526
6. Lugassy G., and Shapira A. Sensorineural hearing loss associated with vincristine treatment. Blut 61 5 (1990) 320-321
7. Aydogdu I., Ozturan O., Kuku I., Kaya E., Sevinc A., and Yildiz R. Bilateral transient hearing loss associated with vincristine therapy: case report. J. Chemother. 12 (2000) 530-532
8. Serafy A. The effect of vincristine on the neurological elements of the rabbit cochlea. J. Laryngol. Otol. 95 (1981) 49-54
9. Collet L. Use of otoacoustic emissions to explore the medial olivocochlear system in humans. Br. J. Audiol. 27 (1993) 155-159
10. Berlin C., Hood L., Hurley A., and Wen H. Contralateral suppression of otoacoustic emissions: an index of the function of the medial olivocochlear system. Otolaryngol. Head Neck Surg. 110 (1994) 3-21
11. Kawase T., and Liberman M.C. Antimasking effects of the olivocochlear reflex. Enhancement of compound action potentials to masked tones. J. Neurophysiol. 70 (1993) 2519-2532
12. Liberman M.C., and Guinan Jr. J.J. Feedback control of the auditory periphery: anti-masking effects of middle ear muscles vs. olivocochlear efferents. J. Commun. Disord. 31 (1998) 471-482
13. Reinders-Messelink H., Van Weerden T., Fock J., Gidding C., Vingerhoets H., Schoemaker M., Göeken L., Bökkerink J., and Kamps W. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia. Eur. J. Paediatr. Neurol. 4 (2000) 225-233
14. Kujawa S., and Liberman M. Conditioning related protection from acoustic injury: effects of chronic deefferentation and sham surgery. J. Neurophysiol. 78 (1997) 3095-3106
15. Rajan R. Effect of electrical stimulation of the crossed olivocochlear bundle on temporary threshold shifts in auditory sensitivity: Dependence on electrical stimulation parameters. J. Neurophysiol. 60 (1998) 549-568
16. Scharf B., Magnan J., Collet L., Ulmer E., and Chays A. On the role of the olivocochlear bundle in hearing: a case study. Hear Res. 75 (1994) 11-26
17. Walsh E.J., McGee J., McFadden S.L., and Liberman M.C. Long term effects of sectioning the olivocochlear bundle in neonatal cats. J. Neurosci. 18 (1998) 3859-3869
18. Vetter D.E., Liberman M.C., Mann J., Barhanin J., Boulter J., Brown M.C., Saffiote-Kolman J., Heinemann S., and Elgoyhen A.B. Role of α-9 nicotinic Ach receptor subunits in the development and function of cochlear efferent innervation. Neuron 23 (1999) 93-103
19. Littman T., Cullen J., and Bobbin R. The effect of olivocochlear bundle transection on tuning curves and acoustic distortion products. J. Acoust. Soc. Am. 92 (1992) 1945-1952
20. Rajan R., Robertson D., and Johnstone B. Absence of tonic activity of the crossed olivocochlear bundle in determining compound action potentials thresholds, amplitudes and masking phenomena in anaesthetized guinea pigs with normal hearing sensitivities. Hear Res. 44 (1990) 195-208
21. Di Girolamo S., d'Ecclesia A., Quaranta N., Garozzo A., Evoli A., and Paludetti G. Effects of contralateral white noise stimulation on distortion product otoacoustic emissions in myasthenic patients. Hear Res. 162 1-2 (2001) 80-84
22. Namyslowski G., Morawski K., Kossowska I., Lisowska G., Koehler B., and Jarosz-Chobot P. Contralateral suppression of TEOAs in diabetic children. Effects of 1.0 and 2.0 kHz pure tone stimulation-preliminary study. Scand. Audiol. 52 Suppl. (2001) 126-129
23. Quaranta A. Paradoxical effects of contralateral white noise on evoked otoacoustic emissions in ears with acoustic neuroma. Acta Otolaryngol. 120 2 (2000) 227-230
24. Maurer J., Hinni M., Beck A., and Mann W. Effects of contralateral white noise stimulation on transitory evoked otoacoustic emissions in patients with acoustic neuroma. Otolaryngol. Head Neck Surg. 112 (1995) 369-374
25. Maison S., Micheyl C., Andeol G., Gallego S., and Collet L. Activation of medial olivocochlear efferent system in humans: influence of stimulus bandwidth. Hear Res. 140 (2000) 111-125
26. Velenovsky D.S., and Glattke T.J. The effect of noise bandwidth on the contralateral suppression of transient evoked otoacoustic emissions. Hear Res. 164 1-2 (2002) 39-48
27. Collet L., Veuillet E., Bene J., and Morgon A. Effects of contralateral white noise on click-evoked emissions in normal and sensorineural ears: towards an exploration of the medial olivocochlear system. Audiology 31 (1992) 1-7
28. Grandori F., and Ravazzani P. Non-linearities of click-evoked otoacoustic emissions and the derived non-linear technique. Br. J. Audiol. 27 (1993) 97-102
29. Hill J.C., Prasher D.K., and Luxon L.M. Latency of contralateral sound-evoked auditory efferent suppression of otoacoustic emissions. Acta Otolaryngol. (Stockh.) 117 (1997) 343-351
30. Lind O. Contralateral suppression of TEOAEs. Attempts to find a latency. Br. J. Audiol. 28 (1994) 219-225
31. Rossi G., Actis R., Solero P., Rolando M., and Pejrone M.D. Cochlear interdependence and micromechanics in man and their relations with the activity of the medial olivocochlear system (MOES). J. Laryngol. Otol. 107 (1993) 883-891
32. Hood L., Berlin C., Hurley A., Cecola R., and Bell B. Contralateral suppression of transient evoked otoacoustic emissions in humans: intensity effects. Hear Res. 101 (1996) 113-118
33. Gelfand S.A. The contralateral acoustic reflex threshold. In: Silman S. (Ed). The Acoustic Reflex, Basic Principles and Clinical Applications (1984), Academic Press, London 137-186
34. Quasthoff S., and Hartung H.P. Chemotherapy induced peripheral neuropathy. J. Neurol. 249 1 (2002) 9-17
35. E.M.R. Critchley, Neuropathies due to drugs, in: W.B. Matthews (Ed.), Neuropathies, in: P.J. Vinken, G.W. Bruyn, H.L. Klawans (Eds.), Handbook of Clinical Neurology, 1987, pp 293-314, Elsevier Science, Amsterdam, The Netherlands.
36. Green L.S., Donoso J.A., and Heller B.I. Axonal transport disturbances in vincristine induced peripheral neuropathy. Ann. Neurol. 1 (1977) 225-262
37. Sahenk Z., Brady S.T., and Mendell J.R. Studies on the pathogenesis of vincristine-induced neuropathy. Muscle Nerve 10 (1987) 80-84
38. Casey E.B., Jellife A.M., Le Q.P., and Millett Y.L. Vincristine neuropathy. Clinical and electrophysiological observations. Brain 96 (1973) 69-86
39. Dambska M., Muzylak M., and Maslinska D. The features of peripheral nerve lesions in young and adult rabbits after vincristine administration. Folia Neuropathol. 33 (1995) 21-24
40. Caccia M.R., Comotti B., and Ubiali E. Vincristine polyneuropathy in man. J. Neurol. 216 (1977) 21-26
41. DeAngelis L.M., Gnecco C., Taylor L., and Warrell R.P. Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-Hodgkin's lymphoma. Cancer 67 (1991) 2241-2246
42. Kujawa S.G., Glattke T.J., Fallon M., and Bobbin R.P. Contralateral sound suppresses distortion product otoacoustic emissions through cholinergic mechanisms. Hear Res. 68 (1993) 97-106
43. Lopez I., and McKay D.B. Effects of antimitotic agents on secretion and detergent extractability of adrenal nicotinic acetylcholine receptors. Cell Mol. Neurobiol. 17 5 (1997) 447-454
44. Lynch J.J., Wade C.L., Mikusa J.P., Decker M.W., and Honore P. ABT-594 (a nicotinic acetycholine agonist): anti-allodynia in a rat chemotherapy-induced pain model. Eur. J. Pharmacol. 509 1 (2005) 43-48
45. Oakes S.G., Santone K.S., and Powis G. Effect of some anticancer drugs on the surface membrane electrical properties of differentiated murine neuroblastoma cells. J. Natl. Cancer Inst. 79 1 (1987) 155-161
46. Fiekers J.F. Effects of the aminoglycoside antibiotics, streptomycin and neomycin on neuromuscular transmission, I Presynaptic considerations. J. Pharmacol. Exp. Ther. 225 (1983) 487-495
47. Fiekers J.F. Effects of the aminoglycoside antibiotics, streptomycin and neomycin on neuromuscular transmission, I Postsynaptic considerations. J. Pharmacol. Exp. Ther. 225 (1983) 496-502